Laskowitz et al. (2009) showed that a panel of four biomarkers (D-dimer, B-type natriuretic peptide (BNP), matrix metalloproteinase 9 (MMP-9), and S100β) improved stroke diagnosis compared to individual markers alone [44]. This evidence concerns the gene MMP9 and stroke disorder.